A detailed history of Lri Investments, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Lri Investments, LLC holds 120 shares of CORT stock, worth $8,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Holding current value
$8,830
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 25, 2025

BUY
$62.24 - $91.93 $7,468 - $11,031
120 New
120 $8.81 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.88B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.